Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Sandoz announced the introduction of tacrolimus capsules, a generic equivalent of Prograf, in the US. Tacrolimus is an immunosuppressive treatment used to help prevent rejection of a kidney or liver transplant. Sandoz is the first and only company to launch generic tacrolimus in the US, delivering on its strategy of being first–to–market with key products. With the introduction of tacrolimus, Sandoz is expanding patient access to cost–saving transplant treatment options in the US.

Today in Medical Devices/Products...keeping you current

Genzyme Begins Shipping Newly Produced Cerezyme from Allston Plant
Genzyme, 12/02/09

Bayer's Betaferon approved in China for Treatment of Multiple Sclerosis
BayNews International, 12/02/09

Allos Therapeutics Announces Issuance of U.S. Patent for FOLOTYN
Allos Therapeutics, 12/01/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address